Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies

Published:2015-10-29 Issue:8 Volume:16 Page:541-551
ISSN:1466-4879
Container-title:Genes & Immunity
language:en
Short-container-title:Genes Immun

Author:

Maziarz M, ,Hagopian W,Palmer J P,Sanjeevi C B,Kockum I,Breslow N,Lernmark Å

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Immunology

Link

http://www.nature.com/articles/gene201543.pdf

Reference66 articles.

1. In't Veld P, Marichal M . Microscopic anatomy of the human islet of Langerhans. Adv Exp Med Biol 2010; 654: 1–19.

2. La Torre D, Lernmark A . Immunology of beta-cell destruction. Adv Exp Med Biol 2010; 654: 537–583.

3. Ziegler AG, Nepom GT . Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32: 468–478.

4. Bluestone JA, Herold K, Eisenbarth G . Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464: 1293–1300.

5. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004; 89: 3896–3902.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary hyperaldosteronism associated with type 3 autoimmune polyendocrine syndrome: A rare case report;Clinical Case Reports;2024-08

2. CTLA4,SH2B3, andCLEC16Adiversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients;Clinical and Experimental Immunology;2023-01-09

3. Pathophysiology of Type 1 Diabetes;The Diabetes Textbook;2023

4. The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients;Microvascular Research;2022-09

5. Advanced Approaches in Immunotherapy for the Treatment of Type 1 Diabetes Mellitus;EMJ Diabetes;2020-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3